Jinshazhou Hospital of Guangzhou University of Chinese Medicine – also known as Golden Sand Bay Hospital (GSB) – is a Grade III comprehensive hospital approved by the Guangzhou Health and Family Planning Commission, which integrates medical treatment, education, research, and preventive care.
Chosen as a key livelihood project by the Guangzhou Municipal Government, the hospital is designated as the medical insurance, work injury, maternity insurance, and public medical care hospital for Guangzhou city. GSB is also proudly the Master’s / Doctoral mentor training base for Guangzhou Medical University of Chinese Medicine.
GSB takes its social responsibilities seriously and is proactive in providing regular free medical services for the local neighbourhood communities. These generous acts have won much praise from the more than 700,000 local residents.
Conveniently located at No. 1, Lichuan East Street, Jinshazhou, Guangzhou, the hospital is 36 kilometers from the Guangzhou International Airport, is close to multiple bus stops, and is only 200 meters from the Hengsha Station on Metro Line 6.
Employing more than 1,200 people, the hospital occupies an area of 34,000 square meters, with an additional 100,000 square meters allocated for medical staff housing.
Equipped with 1,200 in-patient beds and 20 intensive care (ICU) beds, the hospital has 19 modern operating theatres fitted with Laminar Airflow Systems.
Golden Sand Bay’s hundreds of medical professionals and support staff provide a complete range of patient services on par with other highest calibre international medical institutions.
The hospital boasts many clinical departments, incorporating all the specialist fields required under the Chinese Hospital Grade System to achieve their Grade III status. The departments include:
- Emergency Medicine
- Functional Medicine
- Gynaecology & Obstetrics
- Health Management
- Internal Medicine
- Traditional Chinese Medicine
The hospitals cutting-edge Advanced Diagnostic Equipment includes:
- Da Vinci Surgical Robot
- 2 sets of PET-CT
- 3.0T Magnetic Resonance Imaging
- 64-Row 128-Layer Spiral CT
- Gamma Knife
- Angiodynamics NanoKnife 3.0 System
- DSA Hyperbaric Oxygen Chamber
The examination centre can carry out more than 2,600 tests a day and the Pathology Laboratory is certified under the international quality standard (College of American Pathologists) CAP ISO 15189 program.
GSB set out to build an outstanding professional medical platform based on the Chinese proverb of – “Build the nest to attract the Phoenix”. It’s fair to say this plan has succeeded as the hospital has since established a number of specialised centres lead by combined teams of Chinese and international experts. These include:
- International Cancer Medical Centre
- Guangzhou Intelligent Robot-Assisted Surgery Consultation Centre
- Orthopaedics Diagnosis and Treatment Centre
- Minimal Invasive Diagnosis and Treatment Centre
- Emergency and Critical Care Centre
Among them, the Orthopaedic Centre is a key project and a highly accomplished department. With hospital President Dr Wensheng Liu as the academic leader, this specialised department focuses on the treatment of spinal diseases. The centre employs a team of vastly experienced and well-versed orthopaedical experts, who bring together the best of Chinese and Western medicine with an emphasis on minimally invasive techniques. This combined expertise allows the world-class centre to provide comprehensive treatment, utilising extensive orthopaedic practices on a wide range of orthopaedic diseases.
The International Cancer Centre is a joint Chinese – Australian venture, between Jinshazhou Hospital and the ICON Group, Australia’s leading cancer care service provider. Led by Yang Wang, Ph.D., an internationally renowned medical physicist and the Vice President of Jinshazhou Hospital and Director of the International Cancer Centre, the Centre is equipped with cutting-edge medical technologies and an experienced medical team at the forefront of the cancer research. The University of Wollongong in Australia also collaborates with the Centre to provide medical physics training, research, and education.
This centre is equipped with some of the most cutting-edge equipment available today which includes:
- Varian Truebeam and Halcyon Linear Accelerator
- Ankerui M6 Full-digital Radiosurgery CyberKnife
- Angiodynamics NanoKnife 3.0 System
- Siemens Somatom Confidence Four-dimensional Large-aperture CT Analog Positioning Machine,
- Varian HDR/LDR Cavity Close-range Radiation Therapy Equipment.
All equipment is supported by CT/MR/PET-CT imaging and carries out Static/Dynamic Radiation Therapy in all directions, including three-dimensional conformity, volumetric intensity, three-dimensional body-oriented radiosurgery, respiratory-gated radiation therapy, short-distance, and particle-implanted irradiation technologies.
Further confirmation that the International Cancer Centre is truly world-class, came with the recent announcement that Mevion Medical Systems will supply GSB with a Mevion S250i Proton Therapy System with HYPERSAN Pencil Beam Scanning – making it the first compact proton therapy system in the Guangdong-Hong Kong-Macau Greater Bay Area.
Proton therapy is an advanced form of radiation therapy that reduces unnecessary radiation to healthy tissue and prevents complications and secondary cancers. Mevion’s leading HYPERSCAN Pencil Beam Scanning technology further enhances these benefits with a faster and sharper dose delivery, which can be a collimated layer-by-layer to deliver a more precise and conformal dose to the tumour.
“We are pleased to be partnering with Mevion to make proton therapy available to benefit cancer patients in South China,” said Wensheng Liu, President of Jinshazhou Hospital. “MEVION S250i system is the most advanced proton therapy system available today and represents the best overall proton therapy solution. Its addition will position Jinshazhou Hospital as a world-class radiation therapy centre. We look forward to elevating our cancer treatment, research capabilities, and medical education to the next level with protons.”
The new Mevion system is expected to be available for treatment in 2021.